$3.42
11.63% day before yesterday
Nasdaq, Sep 06, 10:18 pm CET
ISIN
US3736785078
Symbol
GOVX
Sector
Industry

Geovax Labs Inc Stock price

$3.42
+1.62 90.00% 1M
+1.27 59.07% 6M
-2.00 36.84% YTD
-5.28 60.70% 1Y
-81.03 95.95% 3Y
-11,456.58 99.97% 5Y
-70,499,996.58 100.00% 10Y
Nasdaq, Closing price Fri, Sep 06 2024
-0.45 11.63%
ISIN
US3736785078
Symbol
GOVX
Sector
Industry

Key metrics

Market capitalization $18.00m
Enterprise Value $16.58m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 55.27
P/S ratio (TTM) P/S ratio 60.00
P/B ratio (TTM) P/B ratio negative
Revenue (TTM) Revenue $300.00k
EBIT (operating result TTM) EBIT $-27.24m
Free Cash Flow (TTM) Free Cash Flow $-23.02m
Cash position $1.56m
EPS (TTM) EPS $-13.08
P/E forward negative
P/S forward 9.06
EV/Sales forward 8.34
Short interest 11.93%
Show more

Is Geovax Labs Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Geovax Labs Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Geovax Labs Inc forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Geovax Labs Inc forecast:

Buy
100%

Financial data from Geovax Labs Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
0.30 0.30
-
100%
- Direct Costs 0.08 0.08
14% 14%
27%
0.22 0.22
414% 414%
73%
- Selling and Administrative Expenses 5.49 5.49
3% 3%
1,830%
- Research and Development Expense 22 22
56% 56%
7,293%
-27 -27
38% 38%
-9,053%
- Depreciation and Amortization 0.08 0.08
14% 14%
27%
EBIT (Operating Income) EBIT -27 -27
38% 38%
-9,080%
Net Profit -27 -27
39% 39%
-8,973%

In millions USD.

Don't miss a Thing! We will send you all news about Geovax Labs Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Geovax Labs Inc Stock News

Neutral
GlobeNewsWire
4 days ago
ATLANTA, GA, Sept. 03, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, today announced that its Chairman and CEO, David Dodd, will present at two upcoming investor events:
Neutral
GlobeNewsWire
10 days ago
ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and vaccines against cancer and infectious diseases, today announced that it has entered into a definitive securities purchase agreement with a certain institutional investor for the purchase and sale of 975,610 shares of the Company's common stock (...
Positive
MarketBeat
18 days ago
GeoVax Labs NASDAQ: GOVX is currently a micro-cap biotech stock that multiple Wall Street analysts see massive potential appreciation in. Working on a treatment for a disease that the World Health Organization (WHO) just declared a “public health emergency," investors should be informed about the company.
More Geovax Labs Inc News

Company Profile

GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and cancer using its novel vaccine platform. It focuses on human immunodeficiency virus, zika virus, hemorrhagic fever viruses, and malaria. The company was founded by Harriet Latham Robinson and Donald G. Hildebrand on September 9, 2006 and is headquartered in Smyrna, GA.

Head office United States
CEO David Dodd
Employees 17
Founded 1988
Website www.geovax.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today